Gramicidin
Alternative Names: Gramicidin-DLatest Information Update: 14 Nov 2003
Price :
$50 *
At a glance
- Originator Nonindustrial sources
- Class Antibacterials; Cyclic peptides; Peptide antibiotics
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Transplant rejection
Most Recent Events
- 14 Nov 2003 Discontinued - Preclinical for Transplant rejection in Japan (unspecified route)
- 06 Aug 1998 No-Development-Reported for Transplant rejection in Japan (Unknown route)
- 13 Dec 1995 Preclinical development for Transplant rejection in Japan (Unknown route)